DERENOFYLLINE - PharmaKB

DERENOFYLLINE

Derenofylline is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target adenosine receptor A2a, adenosine receptor A3, adenosine receptor A2b, and adenosine receptor A1.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

3 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

No data

Indications Phases 3

No data

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Heart failure	D006333	EFO_0003144	I50	—	2	—	—	1	3
Renal insufficiency	D051437	—	N19	—	1	—	—	1	2

Indications Phases 1

No data

Indications Without Phase

No data

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	DERENOFYLLINE
INN	derenofylline
Description	Derenofylline is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target adenosine receptor A2a, adenosine receptor A3, adenosine receptor A2b, and adenosine receptor A1.
Classification	Small molecule
Drug class	theophylline derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	OC1CCC(Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1